WFL 0.00% 0.3¢ wellfully limited

Ann: Pharmaceutical Clinical Study Commences, page-4

  1. 34,916 Posts.
    lightbulb Created with Sketch. 480
    Maybe this is a clue?

    The relationship with the Manufacturer is being managed by OBJ’s USA-based pharmaceutical consultant Dr Steve Mellor, who has extensive experience in IBU clinical studies and a longstanding relationship with the Manufacturer’s analgesic team.
 
watchlist Created with Sketch. Add WFL (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.